Previous 10 | Next 10 |
TARRYTOWN, N.Y. and WASHINGTON, D.C., May 19, 2023 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN ) and Society for Science (the Society) announced that Kaitlyn Wang, 17, of San José, CA, won the $75,000 top award in the 2023 Regeneron I...
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) is one of today's top gainers. The company's shares are currently up 1.61% on the day to $759.54. Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The...
2023-05-18 13:00:35 ET Summary Ocular Therapeutix, Inc. is up a lot since my last article. I am neutral to bearish because I don't see the molecule making a space for itself in the long-acting wet AMD space. Gene therapies are the future as long as they can tackle their safety...
Decision ends nearly decade-long patent dispute related to Regeneron-invented Praluent ® (alirocumab) TARRYTOWN, N.Y., May 18, 2023 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN ) applauds the United States Supreme Court’s unanimous opinio...
2023-05-17 10:42:12 ET Regeneron ( NASDAQ: REGN ) CEO Leonard Schleifer said he agrees with the Federal Trade Commission's lawsuit objecting to Amgen's ( NASDAQ: AMGN ) acquisition of Horizon Therapeutics ( NASDAQ: HZNP ). Speaking at a Financial Times ph...
2023-05-16 13:57:03 ET Regeneron Pharmaceuticals, Inc. (REGN) 2023 RBC Capital Markets Global Healthcare Conference May 16, 2023 9:30 AM ET Company Participants Aris Baras – Senior Vice President, Regeneron Genetics Center Christos Kyratsous – Senior Vi...
2023-05-16 01:29:25 ET Summary GSK's operating income margin in Q1 2023 was 29.35%, showing an increase in the previous quarter and the last year. Vaccine sales were $2,493 million in Q1 2023, up 11.9% year-over-year, mainly due to Fluarix and FluLaval, which regulators approved t...
2023-05-13 22:19:05 ET Regeneron Pharmaceuticals, Inc. (REGN) Bank of America Global Healthcare Conference Call May 09, 2023, 16:40 ET Company Participants Ryan Crowe - VP, IR Robert Landry - EVP, Finance & CFO Conference Call Participants Geoff Meach...
2023-05-10 09:53:00 ET Economists at the U.S. Federal Reserve recently uttered the dreaded "R" word. They are now predicting a recession will come later this year. Investors have been bracing for this possibility for a while now, so it shouldn't come as too much of a surprise. Still, r...
2023-05-10 06:21:20 ET Alvotech ( NASDAQ: ALVO ) signed an exclusive agreement with Polifarma Ilac San. ve tic. for the commercialization in Turkey of AVT06, a proposed biosimilar to Regeneron Pharmaceuticals ( REGN ) and Bayer's ( OTCPK:BAYRY ) ( OTCPK:BAYZF ...
News, Short Squeeze, Breakout and More Instantly...
Regeneron Pharmaceuticals Inc. Company Name:
REGN Stock Symbol:
NASDAQ Market:
Regeneron Pharmaceuticals Inc. Website:
A look at the top 10 most actives in the United States Qualigen Therapeutics Inc. (QLGN) rose 111.4% to $0.4341 on volume of 412,713,755 shares Maxeon Solar Technologies Ltd. (MAXN) fell 1.3% to $0.2375 on volume of 280,800,277 shares NVIDIA Corporation (NVDA) rose 1.4% to $129.24 on volu...
2024-07-12 11:00:05 ET Trung Huynh from UBS issued a price target of $1,250.00 for REGN on 2024-07-12 10:18:00. The adjusted price target was set to $1,250.00. At the time of the announcement, REGN was trading at $1092.3075. The overall price target consensus is at $902....
A look at the top 10 most actives in the United States Maxeon Solar Technologies Ltd. (MAXN) rose 3.6% to $0.2493 on volume of 118,503,418 shares Qualigen Therapeutics Inc. (QLGN) rose 94.8% to $0.4 on volume of 100,863,101 shares AgriFORCE Growing Systems Ltd. (AGRI) rose 20.0% to $0.098...